Invention Grant
- Patent Title: IL22 immunoconjugates
-
Application No.: US15608689Application Date: 2017-05-30
-
Publication No.: US10246502B2Publication Date: 2019-04-02
- Inventor: Franziska Sophie Bootz , Dario Neri
- Applicant: PHILOGEN S.P.A.
- Applicant Address: IT Siena
- Assignee: Philogen S.P.A.
- Current Assignee: Philogen S.P.A.
- Current Assignee Address: IT Siena
- Agency: Klarquist Sparkman, LLP
- Priority: GB1512486.0 20150716; GB1517649.8 20151006; GB1521470.3 20151204
- Main IPC: C07K14/54
- IPC: C07K14/54 ; C07K16/18 ; C07K19/00 ; A61K38/20 ; A61K47/68 ; C07K16/30 ; C07K14/78 ; A61K38/00 ; A61K39/00
Abstract:
The application relates to a conjugate comprising interleukin-22 (IL22) and an antibody molecule. The antibody molecule preferably binds an antigen associated with angiogenesis, such as the ED-A isoform of fibronectin. In particular, the application relates to the therapeutic use of such conjugates in the treatment of a disease/disorder, such as autoimmune diseases, including inflammatory bowel disease (IBD).
Public/Granted literature
- US20170305989A1 IL22 IMMUNOCONJUGATES Public/Granted day:2017-10-26
Information query
